logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
F

Friedrich Stölzel

University Hospital Schleswig-Holstein
H指数:42
被引数:7,126

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party

纠正：基于体内T细胞清除（ATG与alemtuzumab）的GVHD预防方案比较，用于接受异基因造血干细胞移植的AML患者，移植预处理强度为中等强度方案：代表EBMT急性白血病工作组进行的登记研究

Bone Marrow Transplantation
IF5.2
2026-10-230
OAAI
Jesús Duque-Afonso; Jürgen Finke; Allain-Thibeault Ferhat; Jacques-Emmanuel Galimard; Francesca Kinsella; Deborah Richardson; Friedrich Stölzel; Eleni Tholouli; Caroline Besley; Matthias Eder; Emma Nicholson; Robert Zeiser; Adrian Bloor; Charles Crawley; Katherine Clesham; Jennifer Byrne; Patrick Medd; Elisa Sala; Caroline Pabst; Jan Vydra; Eva Maria Wagner-Drouet; Alain Gadisseur; Alexandros Spyridonidis; Eolia Brissot; Arnon Nagler; Mohamad Mohty; Fabio Ciceri
Efficacy and safety of the ROCK2-inhibitor belumosudil for chronic GVHD: results from a multicenter retrospective analysis of a large German-Austrian cohort of the belumosudil MAP

ROCK2抑制剤belumosudil对慢性GVHD的疗效与安全性：来自belumosudil MAP大型德奥人群多中心回顾性分析的结果

Bone Marrow Transplantation
IF5.2
2026-10-050
PRE
Udo Holtick; Elisa Sala; Katharina Egger-Heidrich; Mareike Verbeek; Silke Heidenreich; Alexander Denk; Giuliano Filippini Velazquez; Christina Rautenberg; Helene Schmeller; Lasse Jost; Tim Richardson; Christof Scheid; Katrin Strauss; Franziska Taube; Katharina Nickel; Christoph Schmid; Sara Jennrich; Tobias A. W. Holderried; Friedrich Stölzel; Laurenz Steiner; Marius Dohse; Mohamad-Kamal Yaakoub; Normann Steiner; Olaf Penack; Darina Kodzhabasheva; Jochen J. Frietsch; Matthias Stelljes; Caroline Pabst; Ina Rudolph; Guido Kobbe; Claudia Wehr; Kristina Maas-Bauer; Robert Zeiser; Daniel Wolff; Matthias A. Fante
Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party

基于体内T细胞清除（ATG与alemtuzumab）的GVHD预防方案比较：在异基因无关供者移植且采用中间强度预处理方案的患者中治疗AML的登记研究——代表EBMT急性白血病工作组

Bone Marrow Transplantation
IF5.2
2026-09-100
OAAI
Jesús Duque-Afonso; Jürgen Finke; Thibeault Ferhat-Berland; Jacques-Emmanuel Galimard; Francesca Kinsella; Deborah Richardson; Friedrich Stölzel; Eleni Tholouli; Caroline Besley; Matthias Eder; Emma Nicholson; Robert Zeiser; Adrian Bloor; Charles Crawley; Katherine Clesham; Jennifer Byrne; Patrick Medd; Elisa Sala; Caroline Pabst; Jan Vydra; Eva Maria Wagner-Drouet; Alain Gadisseur; Alexandros Spyridonidis; Eolia Brissot; Arnon Nagler; Mohamad Mohty; Fabio Ciceri
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study

吉列替尼与异基因造血干细胞移植序贯治疗复发/难治FMS样酪氨酸激酶3（FLT3）突变急性髓系白血病患者的多中心真实世界研究

British Journal of Haematology
IF3.8
2026-09-050
OAAI
Desiree Kunadt; Sven Zukunft; Christoph Röllig; Stephan Metzelder; Andreas Burchert; Eva Wagner-Drouet; Oliver Kriege; Christoph Schliemann; Matthias Stelljes; Julian Ronnacker; Wolfgang Bethge; Jan Frederic Weller; Björn Steffen; Gesine Bug; Khouloud Kouidri; Claudia Baldus; Lars Fransecky; Elisa Sala; Uwe Platzbecker; Klaus Metzeler; Sabine Kayser; Inken Hilgendorf; Andreas Hochhaus; Tim H. Brümmendorf; Edgar Jost; Anna Dorottya Doleschall; Thomas Schroeder; Jennifer Kaivers; Lambros Kordelas; Udo Holtick; Julia M. Unglaub; Tim Sauer; Paul Sebastian Jäger; Guido Kobbe; Elena Stauffer; Johanna Tischer; Tobias Herold; Normann Steiner; David Nachbaur; Nicolaus Kröger; Jochen J. Frietsch; Sabrina Kraus; Hermann Einsele; Mathias Hänel; Judith Schaffrath; William Krüger; Anne Brandenburg; Tobias A. W. Holderried; Laura Reinhardt; Markus Maulhardt; Christian Thiede; Martin Bornhäuser; Johannes Schetelig; Jan M. Middeke; Friedrich Stölzel; for the German Cooperative Transplant Study Group and Study Alliance Leukemia (SAL)
Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland – part II – expert based recommendations for surveillance and management of side-effects

德国、奥地利和瑞士关于使用onasemnogene abeparvovec进行脊髓性肌萎缩基因治疗的德尔菲共识——第二部分——基于专家的建议：副作用监测和管理

Journal of Neuromuscular Diseases
IF3.4
2026-08-270
PRE
Andreas Ziegler; Claudia Weiß; Katharina Vill; Matthias Baumann; Günther Bernert; Astrid Blaschek; Astrid Eisenkölbl; Marina Flotats-Bastardas; Johannes Friese; Dorothea Holzwarth; Claudia Ganter; Klaus Goldhahn; Andreas Hahn; Maja von der Hagen; Hans Hartmann; Oswald Hasselmann; Veronka Horber; Ralf A Husain; Sabine Illsinger; David Jacquier; Jessika Johannsen; Cornelia Köhler; Heike Kölbel; Michael Kolodzig; Andrea Klein; Astrid Pechmann; Arpad von Moers; Wolfgang Müller-Felber; Christian Rauscher; Gudrun Schreiber; Oliver Schwartz; Joachim Sproß; Georg M Stettner; Corinna Stoltenburg; Eva Stumpe; Regina Trollmann; Gerd Wiegand; Ekkehard Wilichowski; Ulrike Schara; Janbernd Kirschner; Carsten Müller-Tidow; Georg Friedrich Hoffmann; Peter Dreger; Maria-Luisa Schubert; Andreas Ziegler; Stefan Kölker; Thomas Opladen; Ulrike Schara-Schmidt; Nina Rademacher; Bastian von Tresckow; Christian Reinhardt; Marcel Teichert; Veronka Horber; Hendrik Rosewich; Samuel Gröschel; Wolfgang Bethge; Claudia Lengerke; Bärbel Entrich; Claudia Weiß; Angela M. Kaindl; Joanna Schneider; Lisa-Valerie Bitzan; Antonia Busse; Lars Bullinger; Olaf Penack; Maja von der Hagen; Martin Smitka; Josephine Schädlich; Malte von Bonin; Martin Bornhäuser; Raphael Teipel; Astrid Blaschek; Katharina Vill; Wolfgang Müller-Felber; Moritz Tacke; Fabian Hauck; Christoph Klein; Veit Bücklein; Marion Subklewe; Michael von Bergwelt; Regina Trollmann; Fabian Müller; Andreas Mackensen; Dennis Bene; Jessika Johannsen; Ania C. Muntau; Jonas Denecke; Francis Ayuketang Ayuk; Silke Heidenreich; Gesine Bug; Hubert Serve; Julia Riemann; Eva Wagner-Drouet; Beate Hauptrock; Oliver Schwartz; Hélène Guillemot; Heymut Omran; Simon Call; Matthias Stelljes; Georg Lenz; Anna Ossami Saidy; Bertram Glaß; Aleksandar Radujkovic; Sascha Dietrich; Ben-Niklas Bärmann; Friedrich Stölzel; Claudia Baldus; Natalie Schub; Sabine Illsinger; Dieter Haffner; Hans Hartmann; Astrid Pechmann; Janbernd Kirschner; Lutz Hein; Dorothea Holzwarth; Alexandra Klotz; Franziska Busch; Lisa Allenstein; Gabriel Dworschak; Andreas A. Hahn; Bernd A. Neubauer; Marina Flotats-Bastardas; Michael Zemlin; Klaus Goldhahn; Arpad von Moers; Ellen Knierim; Christian Friese; Gudrun Schreiber; Bernd Wilken; Cornelia Köhler; Thomas Lücke; Christoph Hanefeld; Sebahattin Cirak; Antje Westhoff; Kübra Erden; Lisa Benedikter; Sandra Zinke; Gerald Wulf; Wolfram Jung; Justin Hasenkamp
Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis

嵌合抗原受体T细胞疗法在老年（≥70岁）和年轻多发性骨髓瘤患者中疗效相当且安全性一致：一项多中心回顾性分析

Blood Cancer Journal
IF11.6
2026-06-020
OAAI
Philipp Berning; Markus Maulhardt; Hristo Boyadzhiev; Anca-Maria Albici; Snjezana Janjetovic; Anna Ossami Saidy; Christian Schultze-Florey; Simon Call; Friedrich Stölzel; Annamaria Brioli; Michael Daskalakis; Juliane Knust; Justin Hasenkamp; Rebecca Wurm-Kuczera; Alexander Pohlmann; Matthias Stelljes; Cyrus Khandanpour; Ulrike Bacher; Amelie Boquoi; Florian H. Heidel; Hans Christian Reinhardt; Gerald Wulf; Natalie Schub; Bastian von Tresckow; Georg Lenz; Thomas Pabst; Evgenii Shumilov
Inhibition of high CXCR4 with Motixafortide and absence of single-cell MRD predict outcome after AML consolidation.

高CXCR4抑制与Motixafortide及单细胞微小残留病缺失预测AML巩固治疗后结局

Blood
IF23.1
2026-04-160
PRE
Enise Ceran; Sonia Jaramillo Segura; Anne Kathrin Merbach; Christian Rohde; Maxi Wass; Judith Schaffrath; Robert Durruthy-Durruthy; Marc Arribas-Layton; Adam Sciambi; Kathrin Rieger; Axel Nogai; Mathias Hänel; Regina Herbst; Friedrich Stölzel; Christoph Röllig; Edgar Jost; Richard F. Schlenk; Michelle Lotze; Richard Noppeney; Christian Brandts
Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case report

非ICANS神经毒性与CD19定向CAR T细胞疗法及运动和神经认知治疗相关不良事件的 emergence：一个病例报告

Frontiers in Immunology
IF5.9
2026-02-160
OAAI
Torsten Schroeder; Guranda Chitadze; Justina Dargvainiene; Tjark Martens; Niklas Gebauer; Julia Frimmel; Monika Brüggemann; Thomas Valerius; Natalie Schub; Claudia D. Baldus; Christiane Pott; Frank Leypoldt; Klarissa Stürner; Friedrich Stölzel
Author Correction: Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia

作者更正：组蛋白甲基转移酶EZH2的丢失诱导急性髓系白血病对多种药物的耐药性

Nature Medicine
IF50
2026-01-070
OAAI
Stefanie Göllner; Thomas Oellerich; Shuchi Agrawal-Singh; Tino Schenk; Hans-Ulrich Klein; Christian Rohde; Caroline Pabst; Tim Sauer; Mads Lerdrup; Sigal Tavor; Friedrich Stölzel; Sylvia Herold; Gerhard Ehninger; Gabriele Köhler; Kuan-Ting Pan; Henning Urlaub; Hubert Serve; Martin Dugas; Karsten Spiekermann; Binje Vick; Irmela Jeremias; Wolfgang E. Berdel; Klaus Hansen; Arthur Zelent; Claudia Wickenhauser; Lutz P. Müller; Christian Thiede; Carsten Müller-Tidow
Isocitrate dehydrogenase 1 mutations drive downregulation of IL1R1 and dysregulated inflammatory response in acute myeloid leukemia

异柠檬酸脱氢酶1突变驱动白细胞介素1受体1的下调及急性髓系白血病中失调的炎症反应

Blood Cancer Journal
IF11.6
2026-01-060
OAAI
Sophie Steinhäuser; Thomas Beder; Emely Hübner; Dorothea S. Feuereisel; Jonathan Jebens; Nadine Wolgast; Muhammed Bilal Karaca; Kathrin Richter; Nina Hedemann; Britta Steer; Miriam Denker; Sonja Bendig; Monika Brüggemann; Patricia Silva; Lars Fransecky; Martin Neumann; Friedrich Stölzel; Alina M. Hartmann; Timo Gemoll; Lorenz Bastian; Claudia D. Baldus; Simone Lipinski
Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2026-01-010
OAAI
Dendorfer, Stefan Markus; Schmidt-Brucken, Katharina; Kramer, Michael; Steffen, Bjorn; Schliemann, Christoph; Mikesch, Jan-henrik; Alakel, Nael; Herbst, Regina; Hanel, Mathias; Hanoun, Maher; Kaufmann, Martin; Weinbergerova, Barbora; Schafer-Eckart, Kerstin; Sauer, Tim; Neubauer, Andreas; Burchert, Andreas; Baldus, Claudia D.; Mertova, Jolana; Jost, Edgar; Niemann, Dirk; Novak, Jan; Krause, Stefan W.; Scholl, Sebastian; Hochhaus, Andreas; Held, Gerhard; Szotkowski, Tomas; Rank, Andreas; Schmid, Christoph; Fransecky, Lars; Kayser, Sabine; Schaich, Markus; Fiebig, Frank; Haake, Annett; Schetelig, Johannes; Middeke, Jan Moritz; Stolzel, Friedrich; Platzbecker, Uwe; Thiede, Christian; Muller-Tidow, Carsten; Berdel, Wolfgang E.; Ehninger, Gerhard; Mayer, Jiri; Serve, Hubert; Bornhauser, Martin; Rollig, Christoph
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial

阿扎胞苷治疗具有可测量残留病灶的患者中的骨髓增生异常综合征/急性髓系白血病：RELAZA2试验的最终长期结果

Blood
IF23.1
2025-12-100
PRE
Anne Sophie Platzbecker; Julia-Annabell Georgi; Jan Moritz Middeke; Katja Sockel; Rebekka Wehner; Regina Herbst; Dominik Wolf; Claudia D. Baldus; Uta Oelschlägel; Anke Mütherig; Lars Fransecky; Richard Noppeney; Gesine Bug; Katharina S. Götze; Alwin Krämer; Tilmann Bochtler; Matthias Stelljes; Eva Eßeling; Friedrich Stölzel; Malte von Bonin
Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working Party

供者选择对不良风险AML接受造血细胞移植的影响：EBMT急性白血病工作组的研究

Bone Marrow Transplantation
IF5.2
2025-11-290
PRE
Marta Villalba; Allain-Thibeault Ferhat; Tobias Gedde-Dahl; Gerard Socie; Anne Huynh; Igor Wolfgang Blau; Ibrahim Yakoub-Agha; Didier Blaise; Matthias Eder; Edouard Forcade; Renato Fanin; Jakob Passweg; Charles Crawley; Matthias Stelljes; Friedrich Stölzel; Nicolaus Kroeger; Henrik Sengeloev; Patrice Ceballos; Helene Labussiere-Wallet; Xavier Poiré; Jordi Esteve; Bipin Savani; Arnon Nagler; Simona Piemontese; Jaime Sanz; Mohamad Mohty; Fabio Ciceri
Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working Party

使用rATG/ATLG时，匹配同胞供者 allo-HCT 的无GVHD无复发生存率得到改善——EBMT移植并发症工作组登记研究

Bone Marrow Transplantation
IF5.2
2025-09-110
PRE
Agnieszka Piekarska; Mouad Abouqateb; William Boreland; Christophe Peczynski; Jan Maciej Zaucha; Nicolaus Kröger; Robert Zeiser; Fabio Ciceri; Thomas Schroeder; Thomas Luft; Jakob Passweg; Desiree Kunadt; Matthias Stelljes; Igor Wolfgang Blau; Uwe Platzbecker; Ibrahim Yakoub-Agha; Didier Blaise; Anna Maria Raiola; Johanna Tischer; Eva Maria Wagner-Drouet; Julia Winkler; Christoph Schmid; Gerald Wulf; Matthias Edinger; Johan Maertens; Friedrich Stölzel; Jan Vydra; Pavel Zak; Ivan Moiseev; Hélène Schoemans; Olaf Penack; Zinaida Peric
Prognostic Value of Multicolor-Flow Cytometric Measurable Residual Disease Detection in Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation: Potential Role of HLA-DR

异基因造血细胞移植前多色流式细胞术可测量残留病灶检测的预后价值：HLA-DR的潜在作用

clinical lymphoma myeloma leukemia
IF0
2025-08-200
OAAI
Maximilian A. Röhnert; Chiara Löffler; Michael Kramer; Christoph Röllig; Johannes Schetelig; Friedrich Stölzel; Desirée Kunadt; Jan Moritz Middeke; Lars Thielecke; Friedemann Uschner; Ingmar Glauche; Christian Thiede; Martin Bornhäuser; Uta Oelschlägel; Malte von Bonin; Jonas Schadt

研究方向

暂未获取到该数据
M
Martin Bornhäuser
H 指数:96论文数:1,096被引数:3.9万
C
Christoph Röllig
H 指数:58论文数:522被引数:1.6万
J
Johannes Schetelig
H 指数:55论文数:504被引数:1.2万
U
Uwe Platzbecker
H 指数:87论文数:1,521被引数:3.8万
C
Christian Thiede
H 指数:83论文数:694被引数:3.1万
J
Jan Moritz Middeke
H 指数:37论文数:232被引数:4,820
M
Malte von Bonin
H 指数:44论文数:238被引数:7,715
G
Gerhard Ehninger
H 指数:104论文数:1,218被引数:4.9万
F
Fabio Ciceri
H 指数:116论文数:1,423被引数:5.7万
H
Hubert Serve
H 指数:84论文数:722被引数:3.1万